← FDA Drug Approvals (Drugs@FDA)

VERICIGUAT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT PHARMACEUTICALS LTD · Approved 2026-04-20

Drug application

FDA Application #

ANDA220221

Application type

Abbreviated New Drug Application (Generic)

Brand name

VERICIGUAT

Generic name

Vericiguat

Active ingredients

VERICIGUAT

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

TORRENT PHARMACEUTICALS LTD

First approval

2026-04-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown